Thymosin Alpha-1

• Routine immune supportrecommended

  General longevity and thymic support; usually run twice a year (before winter and in spring).

• Acute immune stress

  During acute viral or immune stress.

• 1.5 mg per injection, twice a week (e.g. Mon/Thu) for 5 weeks: 10 doses
• Alternative acute protocol: 1.5 mg daily for 14 days

Route: Subcutaneous: abdominal fat pad or outer thigh.

Timing: Any time; evenings before bed are preferred.

• 10 mg vial + 2.0 mL bacteriostatic water = 5 mg/mL
• 1.5 mg = 0.3 mL = 30 units
• 2 vials for the 15 mg protocol; ~6.7 doses per vial

Refrigerate upright (36-46 °F). Use within 21 days. Roll or swirl; do not shake.

12-16 weeks off. Typically run twice a year (before winter and in spring).

Why:

• Never draw into the same syringe as another compound; use separate syringes and distinct injection sites.
• Inject into a different area of fat than ARA-290.

What sources report this compound changes, or say to check. A record of the evidence, not targets or advice.

• CD4+ T cells (lymphocyte subsets)Reported changeHuman trial

  CD3 and CD4 counts rose with thymosin alpha 1 in sepsis RCTs; the review rates the evidence low quality (small samples, weak reporting). Patients were critically ill, not healthy adults.

  Thymosin alpha 1 in sepsis: systematic review of RCTs (BMC Infect Dis 2016)